1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Gliknik Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity GL-0817, Hiltonol, Sargramostim - Squamous Cell Carcinoma of the Oral Cavity | Phase 2 | Completed | Gliknik Inc. | 80 | 2017-03-30 | 2022-03-08 |
Squamous Cell Carcinoma of Head and Neck (1)
Cyclophosphamide (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · poly ICLC (1) · sargramostim (1)
Hungary (1) · Poland (1) · Russia (1) · Serbia (1) · Spain (1) · Ukraine (1) · United States (1)
2016 (1)